Walsh, E. M., Xing, D., Lippitt, M. H., Fader, A. N., Wethington, S. L., Meyer, C. F., & Gaillard, S. L. (2021). Molecular tumor board guides successful treatment of a rare, locally aggressive, uterine mesenchymal neoplasm. JCO Precision Oncology, 5, 333–339. https://doi.org/10.1200/PO.20.00189

Walsh, E. M., D. Xing, M. H. Lippitt, A. N. Fader, S. L. Wethington, C. F. Meyer, and S. L. Gaillard. “Molecular tumor board guides successful treatment of a rare, locally aggressive, uterine mesenchymal neoplasm.” JCO Precision Oncology 5 (January 1, 2021): 333–39. https://doi.org/10.1200/PO.20.00189.

Walsh EM, Xing D, Lippitt MH, Fader AN, Wethington SL, Meyer CF, et al. Molecular tumor board guides successful treatment of a rare, locally aggressive, uterine mesenchymal neoplasm. JCO Precision Oncology. 2021 Jan 1;5:333–9.

Walsh, E. M., et al. “Molecular tumor board guides successful treatment of a rare, locally aggressive, uterine mesenchymal neoplasm.” JCO Precision Oncology, vol. 5, Jan. 2021, pp. 333–39. Scopus, doi:10.1200/PO.20.00189.

Walsh EM, Xing D, Lippitt MH, Fader AN, Wethington SL, Meyer CF, Gaillard SL. Molecular tumor board guides successful treatment of a rare, locally aggressive, uterine mesenchymal neoplasm. JCO Precision Oncology. 2021 Jan 1;5:333–339.